These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38820548)

  • 1. Time for a change to clozapine haematological monitoring.
    Cheng A; Buten S; Large M
    Australas Psychiatry; 2024 Aug; 32(4):342-345. PubMed ID: 38820548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine treatment in Australia: a review of haematological monitoring.
    Copolov DL; Bell WR; Benson WJ; Keks NA; Strazzeri DC; Johnson GF
    Med J Aust; 1998 May; 168(10):495-7. PubMed ID: 9631674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical pattern of haematological risk with clozapine.
    Gillman K
    Br J Psychiatry; 2000 Jul; 177():88. PubMed ID: 10945101
    [No Abstract]   [Full Text] [Related]  

  • 4. Monitoring the safe use of clozapine: a consensus view from Victoria, Australia.
    Berk M; Fitzsimons J; Lambert T; Pantelis C; Kulkarni J; Castle D; Ryan EW; Jespersen S; McGorry P; Berger G; Kuluris B; Callaly T; Dodd S
    CNS Drugs; 2007; 21(2):117-27. PubMed ID: 17284094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland.
    Ingimarsson O; MacCabe JH; Haraldsson M; Jónsdóttir H; Sigurdsson E
    BMC Psychiatry; 2016 Dec; 16(1):441. PubMed ID: 27955666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agranulocytosis monitoring with Clozapine patients: to follow guidelines or to attempt therapeutic controversies?
    Chandrasekaran PK
    Singapore Med J; 2008 Feb; 49(2):96-9. PubMed ID: 18301833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haematological monitoring in psychiatry.
    Latif Z
    Ir J Med Sci; 2010 Jun; 179(2):317. PubMed ID: 19711017
    [No Abstract]   [Full Text] [Related]  

  • 8. Haematological side effects of clozapine: patient characteristics.
    Miller PR; Cutten AE
    N Z Med J; 1997 Apr; 110(1041):125-7. PubMed ID: 9140414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine haematological monitoring for neutropenia: a global perspective.
    Oloyede E; Blackman G; Whiskey E; Bachmann C; Dzahini O; Shergill S; Taylor D; McGuire P; MacCabe J
    Epidemiol Psychiatr Sci; 2022 Nov; 31():e83. PubMed ID: 36426600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring: Can the regulations be relaxed?
    Schulte PFJ; Veerman SRT; Bakker B; Bogers JPAM; Jongkind A; Cohen D
    Schizophr Res; 2024 Jun; 268():74-81. PubMed ID: 37770377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA changes clozapine monitoring guidelines: Implications for worldwide practice.
    Bastiampillai T; Gupta A; Allison S
    Asian J Psychiatr; 2016 Jun; 21():19-20. PubMed ID: 27208449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland.
    Atkin K; Kendall F; Gould D; Freeman H; Liberman J; O'Sullivan D
    Br J Psychiatry; 1996 Oct; 169(4):483-8. PubMed ID: 8894200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?
    Kang BJ; Cho MJ; Oh JT; Lee Y; Chae BJ; Ko J
    Hum Psychopharmacol; 2006 Aug; 21(6):387-91. PubMed ID: 16933201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine, agranulocytosis, and benign ethnic neutropenia.
    Rajagopal S
    Postgrad Med J; 2005 Sep; 81(959):545-6. PubMed ID: 16143678
    [No Abstract]   [Full Text] [Related]  

  • 15. Neutropenia and Agranulocytosis in Chinese Patients Prescribed Clozapine.
    Lau KL; Yim PH
    East Asian Arch Psychiatry; 2015 Dec; 25(4):164-7. PubMed ID: 26764291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.
    Whiskey E; Taylor D
    CNS Drugs; 2007; 21(1):25-35. PubMed ID: 17190527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Granulocytopenia while using clozapine: continuing or stopping treatment].
    Bogers JP
    Tijdschr Psychiatr; 2007; 49(8):575-9. PubMed ID: 17694491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case study; ethnicity and clozapine, a risky combination?].
    Laan WJ; Ramlal D
    Tijdschr Psychiatr; 2012; 54(9):829-33. PubMed ID: 22961282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haematological toxicity of clozapine and some other drugs used in psychiatry.
    Nooijen PM; Carvalho F; Flanagan RJ
    Hum Psychopharmacol; 2011 Mar; 26(2):112-9. PubMed ID: 21416507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe neutropenia unrelated to clozapine in patients receiving clozapine.
    Taylor D; Vallianatou K; Gandhi S; Casetta C; Howes O; MacCabe J
    J Psychopharmacol; 2024 Jul; 38(7):624-635. PubMed ID: 39041349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.